A citation-based method for searching scientific literature

Celette Sugg Skinner, Joellen M Schildkraut, Donald Berry, Brian Calingaert, P Kelly Marcom, Jeremy Sugarman, Eric P Winer, J Dirk Iglehart, P Andrew Futreal, Barbara K Rimer. Genet Test 2002
Times Cited: 50







List of co-cited articles
420 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Michael J Green, Susan K Peterson, Maria Wagner Baker, Gregory R Harper, Lois C Friedman, Wendy S Rubinstein, David T Mauger. JAMA 2004
216
46

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
270
34

The use of videotaped information in cancer genetic counselling: a randomized evaluation study.
A Cull, H Miller, T Porterfield, J Mackay, E D Anderson, C M Steel, R A Elton. Br J Cancer 1998
96
28

Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.
M D Schwartz, J Benkendorf, C Lerman, C Isaacs, A Ryan-Robertson, L Johnson. Cancer 2001
72
22

Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
345
22

Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
Catharine Wang, Richard Gonzalez, Kara J Milliron, Victor J Strecher, Sofia D Merajver. Am J Med Genet A 2005
54
20


Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.
Dejana Braithwaite, Jon Emery, Fiona Walter, A Toby Prevost, Stephen Sutton. J Natl Cancer Inst 2004
131
18


Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Br J Cancer 2004
54
16

Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.
Michael J Green, Susan K Peterson, Maria Wagner Baker, Lois C Friedman, Gregory R Harper, Wendy S Rubinstein, June A Peters, David T Mauger. Genet Med 2005
73
16

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
14

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
14

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
14

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
105
14

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
14

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
598
14

Assessment of genetic testing and related counseling services: current research and future directions.
Catharine Wang, Richard Gonzalez, S D Sofia D Merajver. Soc Sci Med 2004
89
14

Validation of a decisional conflict scale.
A M O'Connor. Med Decis Making 1995
14

Goals of genetic counseling.
B B Biesecker. Clin Genet 2001
118
14



Physicians' recommendations for mammography: do tailored messages make a difference?
C S Skinner, V J Strecher, H Hospers. Am J Public Health 1994
370
12

A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style.
C Lerman, M D Schwartz, S M Miller, M Daly, C Sands, B K Rimer. Health Psychol 1996
141
12

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
12

Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.
Deborah J Bowen, Wylie Burke, Yutaka Yasui, Anne McTiernan, Dale McLeran. Genet Med 2002
28
21

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
12

A randomised controlled trial of a psychoeducational intervention for women at increased risk of breast cancer.
S Appleton, M Watson, R Rush, S Garcia-Minaur, M Porteous, J Campbell, E Anderson, A Cull. Br J Cancer 2004
21
28

Results of a randomized study of telephone versus in-person breast cancer risk counseling.
Almut W Helmes, Julie O Culver, Deborah J Bowen. Patient Educ Couns 2006
52
12

Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer.
Kathleen A Calzone, Sheila A Prindiville, Oxana Jourkiv, Jean Jenkins, Maria DeCarvalho, Dawn B Wallerstedt, David J Liewehr, Seth M Steinberg, Peter W Soballe, Stan Lipkowitz,[...]. J Clin Oncol 2005
57
12

Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences.
Arwen H Pieterse, Margreet G E M Ausems, Alexandra M Van Dulmen, Frits A Beemer, Jozien M Bensing. Am J Med Genet A 2005
59
12

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
10


Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
D A Berry, G Parmigiani, J Sanchez, J Schildkraut, E Winer. J Natl Cancer Inst 1997
253
10

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
10

Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
114
10

Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
388
10


Breast cancer risk counseling improves women's functioning.
Deborah J Bowen, Wylie Burke, Anne McTiernan, Yutaka Yasui, M Robyn Andersen. Patient Educ Couns 2004
53
10

Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. J Clin Oncol 2004
87
10

Patient satisfaction with health care decisions: the satisfaction with decision scale.
M Holmes-Rovner, J Kroll, N Schmitt, D R Rovner, M L Breer, M L Rothert, G Padonu, G Talarczyk. Med Decis Making 1996
386
10

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
10

Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service.
Suzanne M Miller, Linda Fleisher, Pagona Roussi, Joanne S Buzaglo, Robert Schnoll, Elyse Slater, Susan Raysor, Melania Popa-Mabe. J Health Commun 2005
47
10

Effects of a mammography decision-making intervention at 12 and 24 months.
Barbara K Rimer, Susan Halabi, Celette Sugg Skinner, Isaac M Lipkus, Tara S Strigo, Ellen B Kaplan, Gregory P Samsa. Am J Prev Med 2002
103
10

Interventions to improve recall of medical information in cancer patients: a systematic review of the literature.
Nienke van der Meulen, Jesse Jansen, Sandra van Dulmen, Jozien Bensing, Julia van Weert. Psychooncology 2008
95
10


QUOTE-gene(ca): development of a counselee-centered instrument to measure needs and preferences in genetic counseling for hereditary cancer.
Arwen Pieterse, Sandra van Dulmen, Margreet Ausems, Angela Schoemaker, Frits Beemer, Jozien Bensing. Psychooncology 2005
45
11

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
Claire E Wakefield, Bettina Meiser, Judi Homewood, Michelle Peate, Alan Taylor, Elizabeth Lobb, Judy Kirk, Mary-Anne Young, Rachel Williams, Tracy Dudding,[...]. Breast Cancer Res Treat 2008
52
10


BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002
325
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.